(BBC): A review by the EU's medicines regulator has concluded the Oxford-AstraZeneca Covid-19 vaccine is "safe and effective", and its benefits outweigh the risks.
The European Medicines Agency (EMA) conducted its review after 13 EU states suspended use of the vaccine over fears of a link to blood clots.
The EMA found the vaccine was "not associated" with higher risk of clots.
But it said it would continue to study the possibility of such links.
The EMA investigation focused on a small number of cases of unusual blood disorders. In particular, it was looking at cases of cerebral venous thrombosis - blood clots in the head.
Decisions to suspend use of the vaccine sparked concerns over the pace of the region's vaccination drive, which had already been affected by supply shortages.